Literature DB >> 29565153

Inflammatory cytokines and non-alcoholic fatty liver disease (NAFLD) in obese children and adolescents.

Silvana Neves Ferraz de Assunção1, Ney Christian Amaral Boa Sorte, Crésio De Aragão Dantas Alves, Patrícia S Almeida Mendes, Carlos Roberto Brites Alves, Luciana Rodrigues Silva.   

Abstract

INTRODUCTION: Non-alcoholic fatty liver disease is characterized by the intrahepatic deposition of fat. It is the most prevalent liver disease in the world, affecting obese children and adolescents. Its pathophysiology is not fully understood, although it is often related to insulin resistance. This in turn would be due to an inflammatory condition common to obesity. Thus, the objective of this study was to describe the behavior of proinflammatory cytokines in obese children and adolescents, with and without non-alcoholic fatty liver disease.
METHOD: A fasting venous blood sample was obtained of consecutive 90 obese individuals aged 8-18 years, of both sexes, for laboratory determinations of glycaemia, basal insulin and homeostasis model assessment insulin-resistance index, and the inflammatory markers tumor necrosis factor-alpha (TNF-α), interleukins 2 and 6 (IL-2 and IL-6), interferon-gamma and high sensitive C-reactive protein. The clinical evaluation included weight, height and waist circumference. We used the body mass index/age indicator for the severity of overweight assessment. The degrees of steatosis were determined by ultrasonography. Quantitative and qualitative variables were respectively expressed by measures of central tendency/dispersion and simple/relative frequency, using Statistical Program for Social Sciences, version 20.0. A p-value < 0.05 was considered as significant.
RESULTS: A total of 90 individuals were studied, with a mean age of 11.98 (2.72) years, of which 48 (53%) were male. The body mass index (BMI) for age (BMI/i) and sex (z-score) classified 38 (42.2%) participants as obese and 52 (57.7%) as severe obese; Hepatic steatosis was identified in 56 (62.2%) participants and approximately 90% of them presented grade I steatosis. The inflammatory markers TNF-α, and C-reactive protein were increased in the studied sample and correlated in a positive and statistically significant way with the index of body mass/age and sex.
CONCLUSION: Hepatic steatosis was prevalent in the group of children and adolescents studied, but was not related to obesity degrees.

Entities:  

Mesh:

Substances:

Year:  2018        PMID: 29565153     DOI: 10.20960/nh.1317

Source DB:  PubMed          Journal:  Nutr Hosp        ISSN: 0212-1611            Impact factor:   1.057


  8 in total

1.  Berberine inhibits liver damage in rats with non-alcoholic fatty liver disease by regulating TLR4/MyD88/NF-κB pathway.

Authors:  Lingling Wang; Zhandong Jia; Bangcai Wang; Bin Zhang
Journal:  Turk J Gastroenterol       Date:  2020-12       Impact factor: 1.852

2.  Development of metabolic inflammation during pre-hibernation fattening in 13-lined ground squirrels (Ictidomys tridecemlineatus).

Authors:  Michelle M Sonsalla; Santidra L Love; Laurana J Hoh; Lauren N Summers; Hannah M Follett; Aminata Bojang; Khrystyne N Duddleston; Courtney C Kurtz
Journal:  J Comp Physiol B       Date:  2021-06-24       Impact factor: 2.200

3.  Heightened Plasma Levels of Transforming Growth Factor Beta (TGF-β) and Increased Degree of Systemic Biochemical Perturbation Characterizes Hepatic Steatosis in Overweight Pediatric Patients: A Cross-Sectional Study.

Authors:  Junaura R Barretto; Ney Boa-Sorte; Caian L Vinhaes; Hayna Malta-Santos; Jessica Rebouças-Silva; Camila F Ramos; Monica A S Torres-Nascimento; Valeria M Borges; Bruno B Andrade
Journal:  Nutrients       Date:  2020-06-02       Impact factor: 5.717

4.  Non-Alcoholic Fatty Liver Disease in Overweight Children: Role of Fructose Intake and Dietary Pattern.

Authors:  Anika Nier; Annette Brandt; Ina Barbara Conzelmann; Yelda Özel; Ina Bergheim
Journal:  Nutrients       Date:  2018-09-19       Impact factor: 5.717

Review 5.  Saturated Fatty Acids in Obesity-Associated Inflammation.

Authors:  Heping Zhou; C J Urso; Viren Jadeja
Journal:  J Inflamm Res       Date:  2020-01-06

6.  Label-free metabolic imaging of non-alcoholic-fatty-liver-disease (NAFLD) liver by volumetric dynamic optical coherence tomography.

Authors:  Pradipta Mukherjee; Shinichi Fukuda; Donny Lukmanto; Toshiharu Yamashita; Kosuke Okada; Shuichi Makita; Ibrahim Abd El-Sadek; Arata Miyazawa; Lida Zhu; Rion Morishita; Antonia Lichtenegger; Tetsuro Oshika; Yoshiaki Yasuno
Journal:  Biomed Opt Express       Date:  2022-06-30       Impact factor: 3.562

Review 7.  Abnormal metabolic processes involved in the pathogenesis of non-alcoholic fatty liver disease (Review).

Authors:  Mingmei Shao; Zixiang Ye; Yanhong Qin; Tao Wu
Journal:  Exp Ther Med       Date:  2020-08-28       Impact factor: 2.447

8.  Is melatonin associated with pro-inflammatory cytokine activity and liver fibrosis in non-alcoholic fatty liver disease (NAFLD) patients?

Authors:  Masoudreza Sohrabi; Ali Gholami; Bahareh Amirkalali; Mahsa Taherizadeh; Mahsa Kolahdoz; Fahimeh SafarnezhadTameshkel; Sheida Aghili; Marzieh Hajibaba; Farhad Zamani; Mohsen Nasiri Toosi; Hossein Keyvani
Journal:  Gastroenterol Hepatol Bed Bench       Date:  2021
  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.